Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry

OBJECTIVES: To evaluate the prevalence of late-onset neutropenia and its complications in patients treated with rituximab (RTX) for rheumatoid arthritis (RA) and other autoimmune diseases (AIDs) in a prospective registry. METHODS: The AutoImmunity and Rituximab registry is an independent 7-year pros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: Salmon, J H, Cacoub, P, Combe, B, Sibilia, J, Pallot-Prades, B, Fain, O, Cantagrel, A, Dougados, M, Andres, E, Meyer, O, Carli, P, Pertuiset, E, Pane, I, Maurier, F, Ravaud, P, Mariette, X, Gottenberg, J E
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2015
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4612695/
https://ncbi.nlm.nih.gov/pubmed/26509060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000034
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados